Loading…

Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis

Background/Aims Serum free fatty acid (FFA) composition and abnormal fatty acid metabolism have been implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, we determined if the serum FFA composition can provide accurate diagnosis of NASH. Methods We compared fasting serum...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2011-10, Vol.56 (10), p.3045-3052
Main Authors: Tomita, Kengo, Teratani, Toshiaki, Yokoyama, Hirokazu, Suzuki, Takahiro, Irie, Rie, Ebinuma, Hirotoshi, Saito, Hidetsugu, Hokari, Ryota, Miura, Soichiro, Hibi, Toshifumi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3
cites cdi_FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3
container_end_page 3052
container_issue 10
container_start_page 3045
container_title Digestive diseases and sciences
container_volume 56
creator Tomita, Kengo
Teratani, Toshiaki
Yokoyama, Hirokazu
Suzuki, Takahiro
Irie, Rie
Ebinuma, Hirotoshi
Saito, Hidetsugu
Hokari, Ryota
Miura, Soichiro
Hibi, Toshifumi
description Background/Aims Serum free fatty acid (FFA) composition and abnormal fatty acid metabolism have been implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, we determined if the serum FFA composition can provide accurate diagnosis of NASH. Methods We compared fasting serum FFA compositions in 20 patients with simple steatosis to those in 77 patients with NASH, including 65 patients with early-stage NASH. Results By univariate analysis, the proportions of serum free myristic acid ( P  = 0.002) and palmitoleic acid ( P  = 0.033) and the stearoyl CoA desaturase (SCD)-1 index ( P  = 0.047) were significantly elevated in NASH patients in comparison to patients with simple steatosis. Only the serum free myristic acid proportion was significantly elevated in the early-stage NASH group in comparison to the simple steatosis group ( P  = 0.003). Multiple logistic regression analysis demonstrated that the serum free myristic acid proportion was significantly elevated in all patients with NASH ( P  = 0.011) and the subset of patients with early-stage NASH ( P  = 0.012) in comparison to those with simple steatosis. The area under the curve (AUC) for the serum free myristic acid proportion was 0.734 to detect NASH and 0.719 to detect early-stage NASH in comparison to simple steatosis. Conclusions Serum free myristic acid proportion could be a useful independent predictor to differentiate NASH from simple steatosis.
doi_str_mv 10.1007/s10620-011-1712-0
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_893933355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712950202</galeid><sourcerecordid>A712950202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3</originalsourceid><addsrcrecordid>eNp1kU1P3DAQhi3UCpZtfwCXKmrFMXTGXtvJcYVKQaItEu3ZchwbjJJ4a3sP_Pt6lS0ICeSDP-Z5xzPzEnKCcIYA8mtCEBRqQKxRIq3hgCyQS1ZTLpp3ZAEoyhlRHJHjlB4AoJUoDskRRV5ClC7I7c2g06iri2ht9eMx-pS9qdbG99VNDJsQsw9TdZUqXe629yaHWAVX_QyTHky4D0PBb7PVOdzbjc4--_SBvHd6SPbjfl-SPxfffp9f1te_vl-dr69rwxnLNW90w5kzK0lp0xvWcd6IFV-1ppOsdEABG9pRx4ReaYFSdKznDYJxUtheGrYkn-e8mxj-bm3K6iFsY6krqaZlLWOM8wJ9maE7PVjlJxdy1Gb0yah1mVnLgQIt1NkrVFm9Hb0Jk3W-vL8Q4CwwMaQUrVOb6EcdHxWC2pmjZnNUMUftzFFQNJ_29W670fZPiv9uFOB0D-hk9OCinoxPz1yZFOz6WhI6c6mEpjsbnxt_-_d_2MejHA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893933355</pqid></control><display><type>article</type><title>Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis</title><source>Springer Nature</source><creator>Tomita, Kengo ; Teratani, Toshiaki ; Yokoyama, Hirokazu ; Suzuki, Takahiro ; Irie, Rie ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Hokari, Ryota ; Miura, Soichiro ; Hibi, Toshifumi</creator><creatorcontrib>Tomita, Kengo ; Teratani, Toshiaki ; Yokoyama, Hirokazu ; Suzuki, Takahiro ; Irie, Rie ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Hokari, Ryota ; Miura, Soichiro ; Hibi, Toshifumi</creatorcontrib><description>Background/Aims Serum free fatty acid (FFA) composition and abnormal fatty acid metabolism have been implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, we determined if the serum FFA composition can provide accurate diagnosis of NASH. Methods We compared fasting serum FFA compositions in 20 patients with simple steatosis to those in 77 patients with NASH, including 65 patients with early-stage NASH. Results By univariate analysis, the proportions of serum free myristic acid ( P  = 0.002) and palmitoleic acid ( P  = 0.033) and the stearoyl CoA desaturase (SCD)-1 index ( P  = 0.047) were significantly elevated in NASH patients in comparison to patients with simple steatosis. Only the serum free myristic acid proportion was significantly elevated in the early-stage NASH group in comparison to the simple steatosis group ( P  = 0.003). Multiple logistic regression analysis demonstrated that the serum free myristic acid proportion was significantly elevated in all patients with NASH ( P  = 0.011) and the subset of patients with early-stage NASH ( P  = 0.012) in comparison to those with simple steatosis. The area under the curve (AUC) for the serum free myristic acid proportion was 0.734 to detect NASH and 0.719 to detect early-stage NASH in comparison to simple steatosis. Conclusions Serum free myristic acid proportion could be a useful independent predictor to differentiate NASH from simple steatosis.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-011-1712-0</identifier><identifier>PMID: 21516322</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adult ; Analysis ; Biochemistry ; Biological and medical sciences ; Biomarkers - blood ; Diagnosis, Differential ; Fatty Acids, Nonesterified - blood ; Fatty Liver - blood ; Fatty Liver - diagnosis ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Gastroenterology ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatology ; Humans ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical colleges ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Monounsaturated fatty acids ; Myristic Acid - blood ; Non-alcoholic Fatty Liver Disease ; Oncology ; Original Article ; Other diseases. Semiology ; Physiological aspects ; Predictive Value of Tests ; Regression Analysis ; Retrospective Studies ; Saturated fatty acids ; Transplant Surgery ; Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><ispartof>Digestive diseases and sciences, 2011-10, Vol.56 (10), p.3045-3052</ispartof><rights>Springer Science+Business Media, LLC 2011</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2011 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3</citedby><cites>FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24720393$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21516322$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tomita, Kengo</creatorcontrib><creatorcontrib>Teratani, Toshiaki</creatorcontrib><creatorcontrib>Yokoyama, Hirokazu</creatorcontrib><creatorcontrib>Suzuki, Takahiro</creatorcontrib><creatorcontrib>Irie, Rie</creatorcontrib><creatorcontrib>Ebinuma, Hirotoshi</creatorcontrib><creatorcontrib>Saito, Hidetsugu</creatorcontrib><creatorcontrib>Hokari, Ryota</creatorcontrib><creatorcontrib>Miura, Soichiro</creatorcontrib><creatorcontrib>Hibi, Toshifumi</creatorcontrib><title>Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Background/Aims Serum free fatty acid (FFA) composition and abnormal fatty acid metabolism have been implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, we determined if the serum FFA composition can provide accurate diagnosis of NASH. Methods We compared fasting serum FFA compositions in 20 patients with simple steatosis to those in 77 patients with NASH, including 65 patients with early-stage NASH. Results By univariate analysis, the proportions of serum free myristic acid ( P  = 0.002) and palmitoleic acid ( P  = 0.033) and the stearoyl CoA desaturase (SCD)-1 index ( P  = 0.047) were significantly elevated in NASH patients in comparison to patients with simple steatosis. Only the serum free myristic acid proportion was significantly elevated in the early-stage NASH group in comparison to the simple steatosis group ( P  = 0.003). Multiple logistic regression analysis demonstrated that the serum free myristic acid proportion was significantly elevated in all patients with NASH ( P  = 0.011) and the subset of patients with early-stage NASH ( P  = 0.012) in comparison to those with simple steatosis. The area under the curve (AUC) for the serum free myristic acid proportion was 0.734 to detect NASH and 0.719 to detect early-stage NASH in comparison to simple steatosis. Conclusions Serum free myristic acid proportion could be a useful independent predictor to differentiate NASH from simple steatosis.</description><subject>Adult</subject><subject>Analysis</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Diagnosis, Differential</subject><subject>Fatty Acids, Nonesterified - blood</subject><subject>Fatty Liver - blood</subject><subject>Fatty Liver - diagnosis</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastroenterology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatology</subject><subject>Humans</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical colleges</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Monounsaturated fatty acids</subject><subject>Myristic Acid - blood</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Other diseases. Semiology</subject><subject>Physiological aspects</subject><subject>Predictive Value of Tests</subject><subject>Regression Analysis</subject><subject>Retrospective Studies</subject><subject>Saturated fatty acids</subject><subject>Transplant Surgery</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1kU1P3DAQhi3UCpZtfwCXKmrFMXTGXtvJcYVKQaItEu3ZchwbjJJ4a3sP_Pt6lS0ICeSDP-Z5xzPzEnKCcIYA8mtCEBRqQKxRIq3hgCyQS1ZTLpp3ZAEoyhlRHJHjlB4AoJUoDskRRV5ClC7I7c2g06iri2ht9eMx-pS9qdbG99VNDJsQsw9TdZUqXe629yaHWAVX_QyTHky4D0PBb7PVOdzbjc4--_SBvHd6SPbjfl-SPxfffp9f1te_vl-dr69rwxnLNW90w5kzK0lp0xvWcd6IFV-1ppOsdEABG9pRx4ReaYFSdKznDYJxUtheGrYkn-e8mxj-bm3K6iFsY6krqaZlLWOM8wJ9maE7PVjlJxdy1Gb0yah1mVnLgQIt1NkrVFm9Hb0Jk3W-vL8Q4CwwMaQUrVOb6EcdHxWC2pmjZnNUMUftzFFQNJ_29W670fZPiv9uFOB0D-hk9OCinoxPz1yZFOz6WhI6c6mEpjsbnxt_-_d_2MejHA</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Tomita, Kengo</creator><creator>Teratani, Toshiaki</creator><creator>Yokoyama, Hirokazu</creator><creator>Suzuki, Takahiro</creator><creator>Irie, Rie</creator><creator>Ebinuma, Hirotoshi</creator><creator>Saito, Hidetsugu</creator><creator>Hokari, Ryota</creator><creator>Miura, Soichiro</creator><creator>Hibi, Toshifumi</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20111001</creationdate><title>Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis</title><author>Tomita, Kengo ; Teratani, Toshiaki ; Yokoyama, Hirokazu ; Suzuki, Takahiro ; Irie, Rie ; Ebinuma, Hirotoshi ; Saito, Hidetsugu ; Hokari, Ryota ; Miura, Soichiro ; Hibi, Toshifumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Analysis</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Diagnosis, Differential</topic><topic>Fatty Acids, Nonesterified - blood</topic><topic>Fatty Liver - blood</topic><topic>Fatty Liver - diagnosis</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastroenterology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatology</topic><topic>Humans</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical colleges</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Monounsaturated fatty acids</topic><topic>Myristic Acid - blood</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Other diseases. Semiology</topic><topic>Physiological aspects</topic><topic>Predictive Value of Tests</topic><topic>Regression Analysis</topic><topic>Retrospective Studies</topic><topic>Saturated fatty acids</topic><topic>Transplant Surgery</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tomita, Kengo</creatorcontrib><creatorcontrib>Teratani, Toshiaki</creatorcontrib><creatorcontrib>Yokoyama, Hirokazu</creatorcontrib><creatorcontrib>Suzuki, Takahiro</creatorcontrib><creatorcontrib>Irie, Rie</creatorcontrib><creatorcontrib>Ebinuma, Hirotoshi</creatorcontrib><creatorcontrib>Saito, Hidetsugu</creatorcontrib><creatorcontrib>Hokari, Ryota</creatorcontrib><creatorcontrib>Miura, Soichiro</creatorcontrib><creatorcontrib>Hibi, Toshifumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tomita, Kengo</au><au>Teratani, Toshiaki</au><au>Yokoyama, Hirokazu</au><au>Suzuki, Takahiro</au><au>Irie, Rie</au><au>Ebinuma, Hirotoshi</au><au>Saito, Hidetsugu</au><au>Hokari, Ryota</au><au>Miura, Soichiro</au><au>Hibi, Toshifumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>56</volume><issue>10</issue><spage>3045</spage><epage>3052</epage><pages>3045-3052</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Background/Aims Serum free fatty acid (FFA) composition and abnormal fatty acid metabolism have been implicated in the pathogenesis of nonalcoholic steatohepatitis (NASH). Therefore, we determined if the serum FFA composition can provide accurate diagnosis of NASH. Methods We compared fasting serum FFA compositions in 20 patients with simple steatosis to those in 77 patients with NASH, including 65 patients with early-stage NASH. Results By univariate analysis, the proportions of serum free myristic acid ( P  = 0.002) and palmitoleic acid ( P  = 0.033) and the stearoyl CoA desaturase (SCD)-1 index ( P  = 0.047) were significantly elevated in NASH patients in comparison to patients with simple steatosis. Only the serum free myristic acid proportion was significantly elevated in the early-stage NASH group in comparison to the simple steatosis group ( P  = 0.003). Multiple logistic regression analysis demonstrated that the serum free myristic acid proportion was significantly elevated in all patients with NASH ( P  = 0.011) and the subset of patients with early-stage NASH ( P  = 0.012) in comparison to those with simple steatosis. The area under the curve (AUC) for the serum free myristic acid proportion was 0.734 to detect NASH and 0.719 to detect early-stage NASH in comparison to simple steatosis. Conclusions Serum free myristic acid proportion could be a useful independent predictor to differentiate NASH from simple steatosis.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>21516322</pmid><doi>10.1007/s10620-011-1712-0</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2011-10, Vol.56 (10), p.3045-3052
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_journals_893933355
source Springer Nature
subjects Adult
Analysis
Biochemistry
Biological and medical sciences
Biomarkers - blood
Diagnosis, Differential
Fatty Acids, Nonesterified - blood
Fatty Liver - blood
Fatty Liver - diagnosis
Feeding. Feeding behavior
Female
Fundamental and applied biological sciences. Psychology
Gastroenterology
Gastroenterology. Liver. Pancreas. Abdomen
Hepatology
Humans
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical colleges
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Monounsaturated fatty acids
Myristic Acid - blood
Non-alcoholic Fatty Liver Disease
Oncology
Original Article
Other diseases. Semiology
Physiological aspects
Predictive Value of Tests
Regression Analysis
Retrospective Studies
Saturated fatty acids
Transplant Surgery
Vertebrates: anatomy and physiology, studies on body, several organs or systems
title Plasma Free Myristic Acid Proportion Is a Predictor of Nonalcoholic Steatohepatitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T10%3A35%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20Free%20Myristic%20Acid%20Proportion%20Is%20a%20Predictor%20of%20Nonalcoholic%20Steatohepatitis&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Tomita,%20Kengo&rft.date=2011-10-01&rft.volume=56&rft.issue=10&rft.spage=3045&rft.epage=3052&rft.pages=3045-3052&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/s10620-011-1712-0&rft_dat=%3Cgale_proqu%3EA712950202%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c533t-58a853fc47228dc3b55864549cb7325620182b2f36a4a6176b3d5810cf76ed7c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=893933355&rft_id=info:pmid/21516322&rft_galeid=A712950202&rfr_iscdi=true